Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

Acute and chronic bacterial prostatitis in outpatients is commonly treated with oral fluoroquinolones; however, the worldwide dissemination of multidrug-resistant (MDR) Escherichia coli has resulted in therapeutic failures with fluoroquinolones. We reviewed the literature regarding the use of oral f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhanel, George G., Zhanel, Michael A., Karlowsky, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831921/
https://www.ncbi.nlm.nih.gov/pubmed/29666664
http://dx.doi.org/10.1155/2018/1404813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831921/
https://www.ncbi.nlm.nih.gov/pubmed/29666664
http://dx.doi.org/10.1155/2018/1404813

Ejemplares similares